Scientific letter
Potential of insulin deprescription adding a GLP-1 receptor agonist as a therapeutic strategy to improve the metabolic profiles of patients with type 2 diabetes mellitus
La deprescripción de insulina mediante agonistas del receptor de GLP-1 como estrategia terapéutica para mejorar el perfil metabólico en pacientes con diabetes mellitus tipo 2
Victor Perez de Arenaza Pozo
, Jersy Cárdenas Salas, Clotilde Vázquez Martínez
Corresponding author
Department of Endocrinology and Nutrition, University Hospital Fundación Jiménez Díaz, Madrid, Spain
Read
329
Timeswas read the article
118
Total PDF
211
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 11 | 3 | 14 |
| 2025 11 | 43 | 58 | 101 |
| 2025 10 | 39 | 28 | 67 |
| 2025 9 | 17 | 8 | 25 |
| 2025 8 | 25 | 10 | 35 |
| 2025 7 | 23 | 8 | 31 |
| 2025 6 | 9 | 2 | 11 |
| 2025 5 | 19 | 1 | 20 |
| 2025 4 | 2 | 0 | 2 |
| 2025 3 | 9 | 0 | 9 |
| 2025 2 | 7 | 0 | 7 |
| 2025 1 | 3 | 0 | 3 |
| 2024 12 | 4 | 0 | 4 |
Show all
